Objective
The overall objective of PHARMANOVA II is the development of technological tools and solutions advanced for the search and development of targeted therapies based on biomolecules natural of plant origin, enabling the design of innovative strategies to prevent and treat the inflammatory processes associated with diseases of the colonic mucosa and colorectal cancer.
Activities
- Development of advanced cell systems for the research of bioactive compounds with application in inflammatory intestinal diseases.
- Research into the fractionation of substances of natural origin with potential therapeutic applicability through SC CO₂ processes.
- Study of therapeutic molecule encapsulation strategies.
- Technology transfer
- Dissemination and communication
- Management and coordination
Dissemination/Transfer
- Press releases
Twelve new R&D projects with the support of IVACE
Biotechnological advances to transform plant waste into compounds against colon inflammation
- Dissemination articles
Innovation in natural therapies for digestive health The PHARMANOVA II project
New advances to discover and target natural therapies against inflammatory colon diseases
Pharmanova II
- Video
Innovative therapies against intestinal inflammation: results of the PHARMANOVA II project
